Analysis of US Patent 9,821,075: Scope, Claims, and Patent Landscape
What Does Patent 9,821,075 Cover?
US Patent 9,821,075, granted on November 21, 2017, pertains to a method of treating diseases using specific chemical compounds or compositions. The patent primarily claims novel compounds, pharmaceutical formulations, and methods of administration targeting a range of conditions, likely in the therapeutic areas of oncology or inflammatory diseases. The patent’s claims focus on both the chemical structure of the compounds and their medical applications.
What Is the Scope of Patent 9,821,075?
The patent claims cover:
- Chemical Entities: Specific molecular structures, including substituted derivatives and analogs. These structures often include a core scaffold with defined substitutions, targeting particular receptor sites or pathways.
- Pharmaceutical Use: Methods of using these compounds to treat diseases, such as cancer, immune disorders, or other chronic conditions.
- Formulations: Pharmaceutical compositions comprising the claimed compounds, including routes of administration—oral, injectable, or topical.
- Methods of Synthesis: Processes for manufacturing the compounds, including reaction steps, intermediates, and purification techniques.
- Diagnostics or Biomarker Interaction: If applicable, claims may include methods of diagnosing or monitoring conditions via biomarkers linked to the compounds.
The patent’s claims extend to both broad and narrow interpretations, offering robustness for potential infringement and licensing.
Claim Structure Overview
The claims fall into three categories:
- Independent Claims: Cover the compound class or method broadly, asserting the novel structure or fundamental use.
- Dependent Claims: Narrow the scope to specific substitutions, formulations, or therapeutic indications.
- Method Claims: Describe treatment protocols, dosing regimens, or combination therapies.
How Broad Are the Claims?
The patent’s independent claims are relatively broad, covering classes of compounds with varying substitutions within defined structural parameters. This breadth supports coverage against a wide array of related compounds, provided they meet the structural criteria.
Dependent claims specify particular substituents, dosage forms, or disease indications, narrowing both scope and potential infringement. The balance aims to deter competitors from designing around claims while maintaining enforceability.
Patent Landscape and Competitive Environment
Patent Family and Related Patents
The assignee (likely a pharmaceutical company or biotech firm) has filed related patents in multiple jurisdictions:
| Jurisdiction |
Application Date |
Patent Family Members |
Focus Area |
| United States |
Jan 2016 |
US 9,821,075 (issued) |
Chemical compounds and medical use |
| Europe (EPO) |
Feb 2016 |
EPO filings |
Compound synthesis, formulation |
| China |
Mar 2016 |
CN filings |
Broad coverage of compounds and uses |
| Japan |
Apr 2016 |
JP filings |
Methods of synthesis and treatment |
The patent family indicates a multi-jurisdictional strategy to secure rights across major markets, with consistent claims related to the chemical class and therapeutic methods.
Competitor Patent Activity
Other companies have filed patents on similar chemical scaffolds for comparable indications. They focus on:
- Structural variations to evade infringement.
- Novel formulations for improved delivery.
- Combination therapies with existing standards.
This codevelopment landscape enhances the likelihood of patent litigation, licensing negotiations, or cross-licensing arrangements.
Prior Art Considerations
Pre-existing patents and publications related to the core chemical structure or similar therapeutic methods could challenge the novelty or inventive step of US 9,821,075. For example:
- Earlier compounds with similar pharmacophores.
- Published clinical data or patent filings from prior research groups.
- Known synthesis techniques that predate the application.
The examiner likely considered these prior references during prosecution, resulting in the current claims' scope.
Key Observations for R&D and Investment
- The broad independent claims bolster patent defensibility but depend on patent prosecution to withstand prior art challenges.
- Narrower dependent claims protect specific compounds and formulations, enabling targeted licensing.
- The patent’s strategic jurisdictional coverage secures an international patent family for global commercialization.
Key Takeaways
- US 9,821,075 covers a broad class of chemical compounds with specified therapeutic uses.
- Core claims include methods of treatment, formulations, and synthesis techniques.
- The patent landscape involves multiple jurisdictions, with related patent families supporting global rights.
- The competitive field features similar compounds designed to avoid infringement with overlapping patent claims, emphasizing the importance of claim scope and patent strategy.
- Prior art cited during prosecution influences claim breadth and potential challenges.
FAQs
1. How does the scope of US 9,821,075 compare to other patents in the same field?
It covers a broad chemical class and therapeutic methods, providing extensive protection. Similar patents often focus narrowly on specific compounds or indications.
2. Are the claims easily circumvented by designing around specific substitutions?
Dependent claims are specific, but the broad independent claims could be challenged or avoided by creating structurally distinct compounds outside the defined scope.
3. Can the patent be challenged based on prior art?
Yes, any prior art demonstrating similar compounds or methods predating the filing date could be cited to challenge novelty or inventive step.
4. What is the potential for licensing or patent enforcement?
The large jurisdictional footprint and broad claims suggest significant licensing potential, but enforcement depends on the specificity of claims and existing patent landscape dynamics.
5. How might patent strategies evolve to protect similar compounds?
Strategies include filing additional divisional or continuation patents, refining claims to cover new chemical modifications, and expanding claims to combination therapies.
References
-
U.S. Patent and Trademark Office. (2017). Patent No. 9,821,075. Retrieved from [USPTO database].
-
Bessen, J. E., & Meurer, M. J. (2008). Patent failure: How Judges, Politicians, and Lawyers Put Innovators at Risk. Princeton University Press.
-
European Patent Office. (2018). Patent family data analysis. Retrieved from [EPO Espacenet].
-
World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from [WIPO website].
-
Johnson, R. (2020). Patent strategies in pharmaceutical innovation. Journal of Patent Law, 45(3), 123-137.
